We demonstrated that among 20 members of the MMP family analysed in our study, only MMP11 and MMP26 gene expression levels are significantly (but oppositely) associated with PCa patients’ clinical outcomes as was also confirmed by other authors [87–89]. Here, MMP11 is linked to posterior cortical atrophy.